Figure 3
From: Microaneurysms cause refractory macular edema in branch retinal vein occlusion

Prompt anti-vascular endothelial growth factor therapy suppressed microaneurysm formation in branch retinal vein occlusion.
Patients, Prompt anti-vascular endothelial growth factor (VEGF) therapy: Fifteen eyes of 15 patients (7 men, 8 women). Delayed anti-VEGF therapy: Twenty-three eyes of 23 patients (13 men, 10 women). (A) The number of microaneurysms that formed after prompt or delayed therapy with anti-VEGF drugs. Prompt was defined as within 3 months and delayed as over 3 months after branch retinal vein occlusion (BRVO) onset. Prompt anti-VEGF treatment significantly (P < 0.05) reduced the microaneurysms formation. (B) The number of total injections of the anti-VEGF drug. There were no significant difference between the two groups. NS, not significant.